SCIENCE TIMES and Fasudil, unlike simvastatin, decreased demonstrated that patients were 1.71 times n = 73) or conscious sedation (CS; the number of multicavernous lesions, more likely to be functional independent n = 77). There was no difference in and improved survival. Further work is at 3 mo if they received endovascular NIHSS in the either group after 24 h. necessary in order to optimize the efficacy therapy. Subgroup meta-analysis of the Forty-one of 47 secondary outcomes were of ROCK inhibition and better define 6 trials with large vessel occlusion (LVO) not significantly different between the 2 pharmacological safety parameters of confirmation demonstrated even better cohorts including overall 3-mo mortality Fasudil administration. functional outcomes. (24.7%). Stratification of modified Rankin These trials have confirmed the signif- scale (mRS) demonstrated improved icant benefit of endovascular therapy functional independence in the GA group Gregory M. Weiner, MD for ischemic stroke patients with LVO. (37.0%) vs CS (18.2%). Hypothermia, AndrewF.Ducruet,MD These studies also highlighted the fact delayed extubation, and pneumonia Department of Neurosurgery that faster recanalization times lead to were all more frequent in the GA University of Pittsburgh improved outcomes. In a recent meta- cohort. Pittsburgh, Pennsylvania analysis of pooled data from
Neurosurgery – Oxford University Press
Published: May 1, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera